Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 08.04.2024 1 Acad Emerg Med 1 Am J Obstet Gynecol 1 Am J Respir Crit Care Med 1 Ann Intern Med 2 Antiviral Res 1 BMJ 3 Clin Infect Dis 7 Emerg Infect Dis 1 Infect Control Hosp Epidemiol 2 Int J Infect Dis 2 J Infect 8 J Med Virol 4 J Virol 2 JAMA 1 Lancet 1 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 3 Nature 1 Radiol Imaging Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acad Emerg Med

1. HOFFMANN JA, Carter CP, Olsen CS, Ashby D, et al
   Pediatric mental health emergency department visits from 2017 to 2022: A multicenter study.
   Acad Emerg Med. 2024 Apr 2. doi: 10.1111/acem.14910.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

2. GABBY LC, Jones CK, McIntyre BB, Manalo Z, et al
   Chronic Villitis as a Distinctive Feature of Placental Injury in Maternal SARS-CoV-2 Infection.
   Am J Obstet Gynecol. 2024 Apr 3:S0002-9378(24)00480.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

3. CURLEY GF, O'Kane CM, McAuley DF, Matthay MA, et al
   Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
   Am J Respir Crit Care Med. 2024;209:789-797.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. GOTUR D, Mylonakis E
   In adults with post-COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0018.
   PubMed         Abstract available
   
   

   
   Antiviral Res

5. SINIAVIN AE, Gushchin VA, Shastina NS, Darnotuk ES, et al
   New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
   Antiviral Res. 2024 Mar 28:105871. doi: 10.1016/j.antiviral.2024.105871.
   PubMed         Abstract available
   
   
6. KHATUA K, Alugubelli YR, Yang KS, Vulupala VR, et al
   Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.
   Antiviral Res. 2024;225:105874.
   PubMed         Abstract available
   
   

   
   BMJ

7. FONG KJ, Summers C, Cook TM
   NHS hospital capacity during covid-19: overstretched staff, space, systems, and stuff.
   BMJ. 2024;385:e075613.
   PubMed        
   
   

   
   Clin Infect Dis

8. TERZIC V, Miantezila Basilua J, Billard N, de Gastines L, et al
   Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
   Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093.
   PubMed         Abstract available
   
   
9. BIERE-RAFI S, Janssen K, Jurgens E, Kooij S, et al
   Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
   Clin Infect Dis. 2023;77:1074-1075.
   PubMed        
   
   
10. GOTTLIEB RL, Kalil AC
    True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
    Clin Infect Dis. 2024 Mar 29:ciae172. doi: 10.1093.
    PubMed        
    
    

    
    Emerg Infect Dis

11. TUNSTALL AM, O'Brien SC, Monaghan DM, Burakoff A, et al
    Lessons Learned from Cross-Systems Approach to COVID-19 Pandemic Response in Juvenile Justice System, Colorado, USA.
    Emerg Infect Dis. 2024;30:S13-S16.
    PubMed         Abstract available
    
    
12. WADDELL C, Meehan A, Schoonveld M, Kaplan Z, et al
    Lessons Learned from COVID-19 Response in Correctional and Detention Facilities.
    Emerg Infect Dis. 2024;30:S5-S12.
    PubMed         Abstract available
    
    
13. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    PubMed         Abstract available
    
    
14. HAGAN LM, Mosites E, Hughes-Baker L, Butler J, et al
    Carceral Health is Public Health.
    Emerg Infect Dis. 2024;30:S1-S4.
    PubMed        
    
    
15. SABER LB, Kennedy SS, Yang Y, Moore KN, et al
    Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail, Atlanta, Georgia, USA.
    Emerg Infect Dis. 2024;30:S21-S27.
    PubMed         Abstract available
    
    
16. PORTER LJ, Rapheal E, Huebsch R, Bastian T, et al
    Development and Evaluation of Surveillance System for Identifying Jail-Associated COVID-19 Cases in Minnesota, USA, 2022.
    Emerg Infect Dis. 2024;30:S28-S35.
    PubMed         Abstract available
    
    
17. KENDIG NE, Bur S, Zaslavsky J
    Infection Prevention and Control in Correctional Settings.
    Emerg Infect Dis. 2024;30:S88-S93.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

18. LEIS JA, Chan CK, Tan C, Callahan J, et al
    Predictors of SARS-CoV-2 transmission in congregate living settings: a multicenter prospective study.
    Infect Control Hosp Epidemiol. 2024 Apr 2:1-6. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

19. CORRECHER-MARTINEZ E, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J, et al
    Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: a population-based, retrospective cohort study.
    Int J Infect Dis. 2024 Apr 2:107037. doi: 10.1016/j.ijid.2024.107037.
    PubMed         Abstract available
    
    
20. SALVADORI N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al
    Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand.
    Int J Infect Dis. 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.
    PubMed         Abstract available
    
    

    
    J Infect

21. COLSON P, Chaudet H, Delerce J, Pontarotti P, et al
    Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
    J Infect. 2024 Apr 1:106150. doi: 10.1016/j.jinf.2024.106150.
    PubMed         Abstract available
    
    
22. NG M, S D, L W, R B, et al
    Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.
    J Infect. 2024 Mar 27:106145. doi: 10.1016/j.jinf.2024.106145.
    PubMed         Abstract available
    
    

    
    J Med Virol

23. HUNG KC, Yu TS, Wang KF, Chen IW, et al
    Influenza vaccination on SARS-CoV-2 infection risk: A subgroup analysis on geographic factor.
    J Med Virol. 2024;96:e29576.
    PubMed        
    
    
24. FAN Y, Huang S, Wu D, Chu M, et al
    Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
    J Med Virol. 2024;96:e29573.
    PubMed         Abstract available
    
    
25. MELE D, Ottolini S, Lombardi A, Conteianni D, et al
    Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination.
    J Med Virol. 2024;96:e29585.
    PubMed         Abstract available
    
    
26. YANG H, Guan L, Yang T, Ma H, et al
    Two- and 3-year outcomes in convalescent individuals with COVID-19: A prospective cohort study.
    J Med Virol. 2024;96:e29566.
    PubMed         Abstract available
    
    
27. GANDIKOTA C, Vaddadi K, Sivasami P, Huang C, et al
    The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
    J Med Virol. 2024;96:e29579.
    PubMed         Abstract available
    
    
28. WOO HG, Kim HJ, Park J, Lee J, et al
    Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database.
    J Med Virol. 2024;96:e29591.
    PubMed         Abstract available
    
    
29. HE S, Liu SQ, Teng XY, He JY, et al
    Comparative single-cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29577.
    PubMed         Abstract available
    
    
30. GUNGOR K, Bukavaz S, Ekuklu G
    Measles outbreak in the adult age group: Clinical, laboratory, and epidemiological features of the 11 patients admitted to the hospital.
    J Med Virol. 2024;96:e29583.
    PubMed         Abstract available
    
    

    
    J Virol

31. ZHU Z, Han Y, Gong M, Sun B, et al
    Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    J Virol. 2024 Apr 1:e0195723. doi: 10.1128/jvi.01957.
    PubMed         Abstract available
    
    
32. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    PubMed         Abstract available
    
    
33. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    PubMed         Abstract available
    
    
34. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    PubMed         Abstract available
    
    

    
    JAMA

35. ANDERER S
    Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
    JAMA. 2024;331:1082.
    PubMed        
    
    
36. GUSSIN GM, McKinnell JA, Singh RD, Miller LG, et al
    Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.
    JAMA. 2024 Apr 1:e242759. doi: 10.1001/jama.2024.2759.
    PubMed         Abstract available
    
    

    
    Lancet

37. KULKARNI PS, Potey AV, Bharati S, Kunhihitlu A, et al
    The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
    Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

38. LARIVIERE Y, Matuvanga TZ, Osang'ir BI, Milolo S, et al
    Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised
    Lancet Infect Dis. 2024 Mar 26:S1473-3099(24)00058.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

39. EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
    Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
    PubMed         Abstract available
    
    

    
    Nature

40. BARNES CO, Jette CA, Abernathy ME, Dam KA, et al
    Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
    Nature. 2024 Apr 2. doi: 10.1038/s41586-024-07344.
    PubMed        
    
    
41. FAIRBANK R
    Long COVID still has no cure - so these patients are turning to research.
    Nature. 2024;628:26-28.
    PubMed        
    
    
42. KANG Y, Hepojoki J, Maldonado RS, Mito T, et al
    Ancestral allele of DNA polymerase gamma modifies antiviral tolerance.
    Nature. 2024 Apr 3. doi: 10.1038/s41586-024-07260.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

43. SPRAGUE BL, Nowak SA, Ahern TP, Herschorn SD, et al
    Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Radiol Imaging Cancer. 2024;6:e230161.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.